A comparative determination of side effects associated with the oral use of three anticholinergic-psychotropic drugs.
D000328:Adult; D002707:Chlordiazepoxide / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003248:Constipation / Q000139:chemically induced; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced; D010276:Parasympatholytics / Q000009:adverse effects*; D010634:Phenobarbital / Q000009:adverse effects; D010919:Placebos; D011413:Propantheline / Q000009:adverse effects; D011812:Quinuclidines / Q000009:adverse effects; D012601:Scopolamine / Q000009:adverse effects; D012737:Sex Factors; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014555:Urination Disorders / Q000139:chemically induced; D014786:Vision Disorders / Q000139:chemically induced; D014987:Xerostomia / Q000139:chemically induced
D010276:Parasympatholytics; D010919:Placebos; D011812:Quinuclidines; D014149:Tranquilizing Agents; D011413:Propantheline; D002707:Chlordiazepoxide; D012601:Scopolamine; D010634:Phenobarbital